Live Breaking News & Updates on Human Immunology Biosciences

Stay updated with breaking news from Human immunology biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Amgen's Soliris Biosimilar & More - This Week in RARE Daily

FDA Approves Amgen's Soliris Biosimilar & More - This Week in RARE Daily
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Amgen-soliris-biosimilar , Amgen-bkemv , Drug-administration , Clinical-hold-on-larimar-friedreich-ataxia-program , Global-genes , Acquires-human-immunology-biosciences , Bolstering-late-stage , Human-immunology-biosciences , Genome-medical-partner , Improve-access , Diagnostic-services , Genome-medical

Merck acquires ophthalmology startup EyeBio

By scooping up EyeBio, Merck is expanding its ophthalmology offerings and bolstering its vision care pipeline. ....

Pearl-bio , David-guyer , Tony-adamis , Merck-research-laboratories , Drug-administration-for-keytruda , Khosla-ventures-backed , Drug-administration , Paris-based-jeito-capital , Human-immunology-biosciences ,

New antibody therapy shows promise in combating kidney transplant rejection

Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term. ....

Austria , Vienna , Wien , Berlin , Germany , Canada , Katharina-mayer , Klemens-budde , Department-of-clinical-pharmacology-bernd-jilma , University-of-vienna , Department-of-medicine , Clinical-division-of-nephrology

Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug

Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Stockholm , Sweden , Swedish , Asahi-kasei , Natsuko-katsuki , Van-lanschot-kempen , Health-partners , Mariana-oncology-inc , Human-immunology-biosciences-inc , Novartis , Asahi-kasei-corp , Biogen-inc

New therapy proven effective against rejection in kidney transplantation

Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term. ....

Canada , Austria , Vienna , Wien , Berlin , Germany , Katharinaa-mayer , Katharina-mayer , Klemens-budde , Department-of-medicine , Clinical-division-of-nephrology , Department-of-clinical-pharmacology-bernd-jilma